Cornelia Keller

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.

G. Jennings, M. Bachmann, K. Timper, 2016, Molecular Therapy.

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy

P. Schmid‐Grendelmeier, M. Donath, C. Cavelti-Weder, 2012, Diabetes Care.

Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes

H. Gast, I. Penner, M. Donath, 2011, Diabetes Care.

Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes

M. Donath, C. Dinarello, T. Mandrup-Poulsen, 2012, Diabetes Care.

Identification of a SIRT1 mutation in a family with type 1 diabetes.

D. Sinclair, B. Glaser, F. Pociot, 2013, Cell metabolism.

Identification of a SIRT 1 Mutation in a Family with Type 1 Diabetes

D. Sinclair, B. Glaser, F. Pociot, 2013 .